Towards  	Towards  	 IN	O
targeted  	targeted  	 JJ	O
epigenetic  	epigenetic  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
of  	of  	 IN	O
cancer  	cancer  	 NN	O
Increasing  	Increasing  	 VBG	O
number  	number  	 NN	O
of  	of  	 IN	O
publications  	publications  	 NNS	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
10  	10  	 CD	O
years  	years  	 NNS	O
implicated  	implicated  	 VBN	O
that  	that  	 IN	O
cancer  	cancer  	 NN	B-NP
development  	development  	 NN	I-NP
depends 	depends 	 VBZ	O
,  	,  	 ,	O
except  	except  	 IN	O
genetic  	genetic  	 JJ	B-NP
alterations 	alterations 	 NN	I-NP
,  	,  	 ,	O
also  	also  	 RB	O
on  	on  	 IN	O
inheritable  	inheritable  	 JJ	B-NP
gene  	gene  	 NN	I-NP
expression  	expression  	 NN	I-NP
patterns  	patterns  	 NNS	I-NP
that  	that  	 WDT	O
are  	are  	 VBP	O
not  	not  	 RB	O
bound  	bound  	 VBN	O
to  	to  	 TO	O
DNA  	DNA  	 NNP	B-NP
sequence  	sequence  	 NN	I-NP
alterations 	alterations 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
epigenetic  	epigenetic  	 JJ	B-NP
mechanisms  	mechanisms  	 NNS	I-NP
manifest  	manifest  	 VBP	O
mostly  	mostly  	 RB	O
through  	through  	 IN	O
changes  	changes  	 NNS	O
in  	in  	 IN	O
chromatin  	chromatin  	 JJ	B-NP
packing  	packing  	 NN	I-NP
and  	and  	 CC	O
in  	in  	 IN	O
localized  	localized  	 JJ	O
gene  	gene  	 NN	B-NP
promoter  	promoter  	 NN	I-NP
changes  	changes  	 NNS	I-NP
that  	that  	 WDT	O
influence  	influence  	 VBP	O
the  	the  	 DT	O
transcription  	transcription  	 NN	B-NP
of  	of  	 IN	O
the  	the  	 DT	O
genes  	genes  	 NNS	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
carcinogenesis 	carcinogenesis 	 NN	B-NP
.  	.  	 .	O
These  	These  	 DT	O
changes  	changes  	 NNS	O
are  	are  	 VBP	O
mitoticaly  	mitoticaly  	 JJ	B-NP
inheritable  	inheritable  	 NN	I-NP
and  	and  	 CC	O
potentially  	potentially  	 RB	O
reversible 	reversible 	 JJ	O
,  	,  	 ,	O
providing  	providing  	 VBG	O
large  	large  	 JJ	O
possibilities  	possibilities  	 NNS	O
of  	of  	 IN	O
epigenetic  	epigenetic  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
of  	of  	 IN	O
cancer 	cancer 	 NN	O
.  	.  	 .	O
So  	So  	 RB	O
far  	far  	 RB	O
this  	this  	 DT	O
therapy  	therapy  	 NN	O
lacks  	lacks  	 VBZ	O
specificity  	specificity  	 VBN	O
of  	of  	 IN	O
targeting  	targeting  	 VBG	O
certain  	certain  	 JJ	O
genes 	genes 	 NNS	O
.  	.  	 .	O
Instead 	Instead 	 RB	O
,  	,  	 ,	O
epigenetic  	epigenetic  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
attempts  	attempts  	 VBZ	O
either  	either  	 RB	O
to  	to  	 TO	O
reactivate  	reactivate  	 VB	O
or  	or  	 CC	O
to  	to  	 TO	O
silence  	silence  	 VB	O
genes  	genes  	 NNS	O
that  	that  	 WDT	O
are  	are  	 VBP	O
important  	important  	 JJ	O
for  	for  	 IN	O
the  	the  	 DT	O
cancer  	cancer  	 NN	B-NP
progress 	progress 	 NN	I-NP
.  	.  	 .	O
Epigenetic  	Epigenetic  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
of  	of  	 IN	O
cancer  	cancer  	 NN	O
is  	is  	 VBZ	O
based  	based  	 VBN	O
mostly  	mostly  	 RB	O
on  	on  	 IN	O
the  	the  	 DT	O
usage  	usage  	 NN	O
of  	of  	 IN	O
inhibitors  	inhibitors  	 NN	O
of  	of  	 IN	O
DNA  	DNA  	 NNP	B-NP
methyltransferases  	methyltransferases  	 NNS	I-NP
( 	( 	 -LRB-	O
DNMTs 	DNMTs 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
histone  	histone  	 FW	B-NP
deacetylase  	deacetylase  	 FW	I-NP
( 	( 	 -LRB-	O
HDAC 	HDAC 	 NNP	B-NP
)  	)  	 -RRB-	O
inhibitors  	inhibitors  	 NN	O
and  	and  	 CC	O
anti-micro-RNA  	anti-micro-RNA  	 JJ	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Developments  	Developments  	 NNS	B-NP
that  	that  	 WDT	O
involve  	involve  	 VBP	O
integration  	integration  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
latest  	latest  	 JJS	O
technological  	technological  	 JJ	B-NP
advances 	advances 	 NNS	I-NP
,  	,  	 ,	O
such  	such  	 JJ	O
as  	as  	 IN	O
whole  	whole  	 JJ	O
genome  	genome  	 JJ	B-NP
microarray  	microarray  	 JJ	I-NP
expression  	expression  	 NN	I-NP
profiling 	profiling 	 NN	I-NP
,  	,  	 ,	O
help  	help  	 VB	O
identify  	identify  	 VB	O
mechanisms  	mechanisms  	 NNS	O
of  	of  	 IN	O
action  	action  	 NN	O
of  	of  	 IN	O
epigenetic  	epigenetic  	 JJ	B-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
leading  	leading  	 VBG	O
to  	to  	 TO	O
development  	development  	 NN	O
of  	of  	 IN	O
second  	second  	 JJ	O
generation  	generation  	 NN	O
of  	of  	 IN	O
epi-drugs  	epi-drugs  	 NN	B-NP
which  	which  	 WDT	O
would  	would  	 MD	O
have  	have  	 VB	O
greater  	greater  	 JJR	O
specificity  	specificity  	 NN	O
and  	and  	 CC	O
efficacy 	efficacy 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
obtained  	obtained  	 JJ	O
results  	results  	 NNS	O
are  	are  	 VBP	O
promising 	promising 	 VBG	O
,  	,  	 ,	O
leaving  	leaving  	 VBG	O
great  	great  	 JJ	O
possibilities  	possibilities  	 NNS	O
for  	for  	 IN	O
improvement  	improvement  	 NN	O
of  	of  	 IN	O
cancer  	cancer  	 NN	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
